Multiple actions of somatostatin in neoplastic disease
- 1 March 1995
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 16 (3) , 110-115
- https://doi.org/10.1016/s0165-6147(00)88992-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumorsLife Sciences, 1994
- The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cellsMolecular Endocrinology, 1994
- Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineageJournal of Clinical Endocrinology & Metabolism, 1994
- Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS‐7 cellsFEBS Letters, 1994
- All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl CyclaseBiochemical and Biophysical Research Communications, 1994
- Molecular biology of somatostatin receptorsTrends in Neurosciences, 1993
- Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160Urological Research, 1992
- Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cellsEndocrinology, 1992
- The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of TumorsEndocrine Reviews, 1991
- A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growthActa Endocrinologica, 1985